The "US against the BOD" line is even more tiresome than the "dead money" argument. If only life was so simple.
I expect Peregrine will produce killer survival data, neat phrase huh, from the Sunrise trial. BPs will offer substantial partnering deals or outright buyouts in their own interest whether they like our BOD or not. Then, we will congratulate the BOD for their outstanding fiduciary duty, and our "dead money" will somehow return to life.
It all depends on the data, and what it means to the people with billions to invest in a significant addition to the treatment of multiple cancers. Oh, and that data will be here in the next few weeks to months. Is that soon enough?
GLTA, Especially Bavi-Arm Sunrise Patients,
Paul